Continuing clozapine treatment after a diagnosis of cardiomyopathy

F Williams1, F Lenihan2, A Rowe3

  • 1NHS Fife, Learning Disability Service, Lynebank Hospital, Dunfermline, Halbeath, Fife, UK.

Insights

Clozapine, a crucial antipsychotic for treatment-resistant schizophrenia, can cause cardiac issues. This case highlights managing cardiomyopathy by continuing clozapine with cardiac medication, avoiding psychosis relapse.

Area of Science:

  • Psychiatry
  • Cardiology
  • Pharmacology

Background:

  • Treatment-resistant schizophrenia presents significant management challenges.
  • Clozapine is highly effective but carries risks, including cardiac side effects.
  • Patient history of violence and treatment resistance complicated management decisions.

Purpose of the Study:

  • To describe the management of a patient with treatment-resistant schizophrenia and clozapine-induced cardiomyopathy.
  • To evaluate the risk-benefit of continuing clozapine versus managing psychosis exacerbation.
  • To illustrate a multidisciplinary approach involving psychiatry and cardiology.

Main Methods:

  • Case report of a patient with schizophrenia on clozapine.
  • Diagnosis of sustained tachycardia and mild biventricular cardiomyopathy via echocardiography.
  • Pharmacological management including ramipril and bisoprolol, alongside continued clozapine therapy.

Main Results:

  • The patient's cardiomyopathy was mild and did not necessitate clozapine discontinuation.
  • Continuing clozapine, with added cardiac medications, successfully managed both psychosis and cardiac function.
  • The patient was successfully discharged from psychiatric care and maintained on clozapine.

Conclusions:

  • Careful risk-benefit assessment is crucial when managing clozapine's cardiac side effects in patients with severe mental illness.
  • Continuing clozapine may be preferable to antipsychotic withdrawal if cardiac risks are manageable.
  • A collaborative approach between psychiatry and cardiology can optimize patient outcomes.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
267
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
69
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
83
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
58
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
79